regulation of intracellular protein transport (GO:0033157) | - | 3.8 | 0.008 | CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of kinase activity (GO:0043549) | - | 3.07 | 0.049 | APC, CASP8, MET, CDKN3, AXIN1, TP53, CTNNB1, PIK3CA |
regulation of phosphate metabolic process (GO:0019220) | - | 2.35 | 0.031 | APC, MET, CDKN3, AXIN1, TP53, CTNNB1, PIK3CA |
regulation of apoptotic signaling pathway (GO:2001233) | - | 3.83 | 0.003 | CASP8, MET, IGF2R, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of intracellular transport (GO:0032386) | - | 3.58 | 0.009 | CASP8, MET, IGF2R, PIK3CA, AXIN1, TP53, CTNNB1 |
activation of protein kinase activity (GO:0032147) | - | 4.08 | 0.006 | CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
male gonad development (GO:0008584) | NEW | 5.08 | 0.036 | TP53, CASP8, PIK3CA, CTNNB1 |
regulation of Wnt signaling pathway (GO:0030111) | - | 3.98 | 0.0 | APC, CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
T cell activation (GO:0042110) | - | 4.45 | 0.005 | APC, CASP8, TP53, CTNNB1 |
enzyme linked receptor protein signaling pathway (GO:0007167) | - | 3.24 | 0.001 | APC, CASP8, MET, PDGFRL, IGF2R, PIK3CA, AXIN1, TP53, CTNNB1 |
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169) | - | 3.54 | 0.0 | APC, CASP8, MET, PDGFRL, IGF2R, PIK3CA, AXIN1, TP53, CTNNB1 |
negative regulation of cell cycle (GO:0045786) | - | 3.67 | 0.0 | APC, CASP8, MET, CDKN3, AXIN1, TP53, CTNNB1, PIK3CA |
regulation of organelle organization (GO:0033043) | - | 2.72 | 0.002 | APC, CASP8, MET, IGF2R, CDKN3, AXIN1, TP53, CTNNB1, PIK3CA |
organ development (GO:0048513) | - | 2.53 | 0.025 | APC, CASP8, MET, IGF2R, TP53, CTNNB1 |
morphogenesis of a branching epithelium (GO:0061138) | - | 4.77 | 0.021 | APC, MET, AXIN1, TP53, CTNNB1 |
regulation of protein sumoylation (GO:0033233) | NEW | 6.68 | 0.003 | AXIN1, TP53, CTNNB1 |
regulation of thymocyte apoptotic process (GO:0070243) | NEW | 7.24 | 0.042 | CASP8, TP53 |
negative regulation of response to stimulus (GO:0048585) | - | 2.52 | 0.017 | APC, CASP8, MET, TP53, AXIN1, CTNNB1 |
neurotrophin signaling pathway (GO:0038179) | NEW | 6.55 | 0.005 | APC, CASP8, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of DNA metabolic process (GO:0051052) | - | 3.87 | 0.009 | APC, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
T cell differentiation (GO:0030217) | NEW | 5.11 | 0.029 | APC, TP53, CTNNB1 |
negative regulation of cell death (GO:0060548) | - | 2.95 | 0.048 | MET, CASP8, TP53, CTNNB1, PIK3CA |
regulation of protein kinase activity (GO:0045859) | - | 3.15 | 0.016 | APC, CASP8, MET, CDKN3, AXIN1, TP53, CTNNB1, PIK3CA |
protein heterooligomerization (GO:0051291) | - | 5.22 | 0.012 | MET, AXIN1, CASP8, CTNNB1 |
regulation of sequence-specific DNA binding transcription factor activity (GO:0051090) | NEW | 3.83 | 0.038 | CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of proteolysis (GO:0030162) | - | 3.2 | 0.03 | APC, CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
regionalization (GO:0003002) | - | 4.24 | 0.012 | APC, AXIN1, TP53, CTNNB1 |
response to peptide hormone (GO:0043434) | NEW | 4.06 | 0.003 | APC, CASP8, MET, PIK3CA, MTUS1, TP53, CTNNB1 |
regulation of phosphorylation (GO:0042325) | - | 2.5 | 0.001 | APC, MET, CDKN3, AXIN1, TP53, CTNNB1, PIK3CA |
negative regulation of phosphorylation (GO:0042326) | NEW | 3.7 | 0.002 | APC, CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of MAP kinase activity (GO:0043405) | NEW | 3.95 | 0.011 | CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028) | - | 5.94 | 0.023 | IGF2R, CASP8, TP53 |
response to hormone (GO:0009725) | NEW | 3.33 | 0.032 | APC, CASP8, MET, PIK3CA, MTUS1, AXIN1, TP53, CTNNB1 |
regulation of microtubule cytoskeleton organization (GO:0070507) | - | 4.98 | 0.027 | APC, AXIN1, TP53, CTNNB1 |
regulation of canonical Wnt signaling pathway (GO:0060828) | - | 4.26 | 0.0 | APC, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
positive regulation of catabolic process (GO:0009896) | - | 3.94 | 0.005 | APC, CASP8, PIK3CA, AXIN1, TP53, CTNNB1 |
cell surface receptor signaling pathway (GO:0007166) | - | 2.09 | 0.005 | APC, CASP8, MET, PDGFRL, IGF2R, PIK3CA, AXIN1, TP53, CTNNB1 |
cellular component disassembly involved in execution phase of apoptosis (GO:0006921) | - | 6.47 | 0.004 | APC, CASP8, CTNNB1 |
positive regulation of kinase activity (GO:0033674) | - | 3.54 | 0.027 | APC, CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
cellular response to mechanical stimulus (GO:0071260) | - | 5.33 | 0.007 | TP53, CASP8, PIK3CA, CTNNB1 |
regulation of DNA binding (GO:0051101) | NEW | 5.21 | 0.012 | APC, AXIN1, TP53, CTNNB1 |
positive regulation of cell migration (GO:0030335) | - | 3.77 | 0.021 | APC, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
platelet-derived growth factor receptor signaling pathway (GO:0048008) | NEW | 6.15 | 0.013 | MET, PDGFRL, TP53 |
morphogenesis of a branching structure (GO:0001763) | - | 4.71 | 0.035 | MET, APC, AXIN1, TP53, CTNNB1 |
regulation of mononuclear cell proliferation (GO:0032944) | NEW | 4.45 | 0.032 | MET, AXIN1, TP53, CTNNB1, PIK3CA |
regulation of catenin import into nucleus (GO:0035412) | NEW | 6.47 | 0.0 | TP53, AXIN1, PIK3CA, CTNNB1 |
regulation of JNK cascade (GO:0046328) | NEW | 4.65 | 0.012 | MET, AXIN1, TP53, CTNNB1, PIK3CA |
regulation of protein serine/threonine kinase activity (GO:0071900) | - | 3.58 | 0.0 | APC, CASP8, MET, CDKN3, AXIN1, TP53, CTNNB1, PIK3CA |
negative regulation of Wnt signaling pathway (GO:0030178) | - | 4.44 | 0.005 | APC, MET, AXIN1, TP53, CTNNB1 |
regulation of myeloid leukocyte differentiation (GO:0002761) | - | 5.02 | 0.029 | APC, CASP8, CTNNB1 |
regulation of mitotic cell cycle (GO:0007346) | - | 3.71 | 0.003 | APC, CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
positive regulation of GTPase activity (GO:0043547) | NEW | 3.28 | 0.009 | APC, CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
positive regulation of immune system process (GO:0002684) | - | 2.96 | 0.012 | APC, CASP8, MET, IGF2R, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of MAPK cascade (GO:0043408) | - | 3.22 | 0.032 | APC, CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
anatomical structure formation involved in morphogenesis (GO:0048646) | - | 3.01 | 0.042 | CASP8, TP53, AXIN1, PIK3CA, CTNNB1 |
ectodermal placode formation (GO:0060788) | - | 7.02 | 0.048 | AXIN1, CTNNB1 |
positive regulation of cellular component organization (GO:0051130) | - | 2.68 | 0.043 | APC, CASP8, MET, IGF2R, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of establishment of protein localization (GO:0070201) | - | 3.02 | 0.04 | CASP8, MET, IGF2R, PIK3CA, AXIN1, TP53, CTNNB1 |
embryonic skeletal joint morphogenesis (GO:0060272) | - | 7.24 | 0.036 | AXIN1, CTNNB1 |
T cell differentiation in thymus (GO:0033077) | NEW | 6.33 | 0.037 | APC, TP53, CTNNB1 |
regulation of behavior (GO:0050795) | NEW | 5.55 | 0.047 | MTUS1, MET, AXIN1, TP53, PIK3CA |
positive regulation of intracellular signal transduction (GO:1902533) | - | 2.95 | 0.036 | MET, AXIN1, CASP8, TP53, CTNNB1 |
cell cycle arrest (GO:0007050) | - | 4.69 | 0.004 | APC, TP53, AXIN1, CTNNB1, CDKN3 |
regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | NEW | 7.53 | 0.018 | APC, CTNNB1 |
cell activation (GO:0001775) | - | 3.47 | 0.015 | APC, TP53, CASP8, PIK3CA, CTNNB1 |
positive regulation of proteolysis (GO:0045862) | - | 3.86 | 0.015 | AXIN1, CASP8, TP53, PIK3CA |
negative regulation of intracellular signal transduction (GO:1902532) | NEW | 3.63 | 0.003 | APC, CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of protein import into nucleus (GO:0042306) | NEW | 4.54 | 0.014 | MET, AXIN1, TP53, CTNNB1, PIK3CA |
regulation of protein complex assembly (GO:0043254) | - | 3.83 | 0.007 | APC, CASP8, MET, TP53, AXIN1, CTNNB1 |
regulation of intracellular signal transduction (GO:1902531) | - | 2.31 | 0.042 | APC, CASP8, MET, TP53, AXIN1, CTNNB1 |
negative regulation of cell cycle phase transition (GO:1901988) | - | 4.74 | 0.009 | MET, APC, TP53, CTNNB1, PIK3CA |
regulation of protein localization to nucleus (GO:1900180) | NEW | 4.34 | 0.025 | MET, AXIN1, TP53, CTNNB1, PIK3CA |
regulation of protein processing (GO:0070613) | NEW | 5.35 | 0.001 | APC, CASP8, PIK3CA, AXIN1, TP53, CTNNB1 |
mitotic cell cycle process (GO:1903047) | - | 3.12 | 0.03 | APC, MET, CDKN3, AXIN1, TP53, CTNNB1, PIK3CA |
dorsal/ventral axis specification (GO:0009950) | - | 7.02 | 0.036 | AXIN1, CTNNB1 |
negative regulation of protein modification process (GO:0031400) | - | 3.4 | 0.006 | APC, CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of cellular response to stress (GO:0080135) | - | 3.4 | 0.006 | APC, CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of transferase activity (GO:0051338) | - | 2.88 | 0.05 | APC, CASP8, MET, CDKN3, AXIN1, TP53, CTNNB1, PIK3CA |
regulation of leukocyte activation (GO:0002694) | - | 3.6 | 0.007 | CASP8, MET, IGF2R, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of cell motility (GO:2000145) | - | 3.16 | 0.004 | APC, CASP8, MET, PIK3CA, MTUS1, AXIN1, TP53, CTNNB1 |
regulation of nucleocytoplasmic transport (GO:0046822) | - | 4.33 | 0.048 | MET, TP53, AXIN1, PIK3CA, CTNNB1 |
positive regulation of cell motility (GO:2000147) | - | 3.74 | 0.024 | APC, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of protein maturation (GO:1903317) | NEW | 5.33 | 0.001 | APC, CASP8, PIK3CA, AXIN1, TP53, CTNNB1 |
olfactory placode formation (GO:0030910) | NEW | 8.34 | 0.015 | AXIN1, CTNNB1 |
regulation of response to external stimulus (GO:0032101) | NEW | 3.06 | 0.008 | APC, MET, IGF2R, PIK3CA, MTUS1, AXIN1, TP53, CTNNB1 |
mammary placode formation (GO:0060596) | NEW | 8.63 | 0.015 | AXIN1, CTNNB1 |
positive regulation of MAP kinase activity (GO:0043406) | NEW | 4.39 | 0.044 | MET, AXIN1, TP53, CTNNB1, PIK3CA |
regulation of protein catabolic process (GO:0042176) | - | 3.83 | 0.004 | APC, CASP8, PIK3CA, AXIN1, TP53, CTNNB1 |
negative regulation of mitotic cell cycle phase transition (GO:1901991) | - | 4.82 | 0.007 | MET, APC, TP53, PIK3CA, CTNNB1 |
regulation of mitotic cell cycle phase transition (GO:1901990) | - | 4.23 | 0.002 | APC, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
glomerular epithelial cell development (GO:0072310) | NEW | 7.43 | 0.0 | AXIN1, TP53, CTNNB1 |
axis specification (GO:0009798) | - | 5.42 | 0.021 | APC, AXIN1, TP53, CTNNB1 |
epidermis development (GO:0008544) | NEW | 5.04 | 0.0 | APC, CASP8, MET, TP53, AXIN1, CTNNB1 |
regulation of GTPase activity (GO:0043087) | NEW | 3.21 | 0.015 | APC, CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of ossification (GO:0030278) | NEW | 4.53 | 0.036 | APC, MET, AXIN1, TP53, CTNNB1 |
negative regulation of MAPK cascade (GO:0043409) | NEW | 4.74 | 0.004 | APC, MET, CASP8, TP53, PIK3CA |
regulation of protein localization (GO:0032880) | - | 2.88 | 0.01 | APC, CASP8, MET, IGF2R, PIK3CA, AXIN1, TP53, CTNNB1 |
activation of JUN kinase activity (GO:0007257) | NEW | 6.17 | 0.0 | MET, AXIN1, TP53, CTNNB1 |
negative regulation of heart induction (GO:1901320) | NEW | 9.73 | 0.006 | AXIN1, CTNNB1 |
regulation of lymphocyte activation (GO:0051249) | - | 3.73 | 0.003 | CASP8, MET, IGF2R, PIK3CA, AXIN1, TP53, CTNNB1 |
negative regulation of phosphorus metabolic process (GO:0010563) | NEW | 3.45 | 0.005 | APC, CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of protein metabolic process (GO:0051246) | - | 1.93 | 0.003 | APC, CASP8, MET, CDKN3, AXIN1, TP53, CTNNB1, PIK3CA |
positive regulation of protein metabolic process (GO:0051247) | - | 2.43 | 0.001 | APC, CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of nucleotide catabolic process (GO:0030811) | NEW | 8.34 | 0.033 | APC, CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of protein modification by small protein conjugation or removal (GO:1903320) | - | 4.14 | 0.015 | MET, TP53, AXIN1, PIK3CA, CTNNB1 |
leukocyte differentiation (GO:0002521) | - | 4.13 | 0.013 | APC, CASP8, TP53, CTNNB1 |
regulation of protein modification process (GO:0031399) | - | 2.32 | 0.002 | APC, MET, CDKN3, AXIN1, TP53, CTNNB1, PIK3CA |
regulation of cell cycle phase transition (GO:1901987) | - | 4.15 | 0.002 | APC, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
negative regulation of cell proliferation (GO:0008285) | - | 3.26 | 0.011 | APC, CASP8, MET, CDKN3, AXIN1, TP53, CTNNB1, PIK3CA |
reproductive structure development (GO:0048608) | NEW | 4.08 | 0.022 | CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of stress-activated protein kinase signaling cascade (GO:0070302) | NEW | 4.44 | 0.001 | CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
epithelium development (GO:0060429) | NEW | 4.57 | 0.018 | APC, CASP8, MET, TP53, AXIN1, CTNNB1 |
positive regulation of stress-activated protein kinase signaling cascade (GO:0070304) | NEW | 4.82 | 0.017 | AXIN1, CASP8, TP53, PIK3CA |
regulation of vesicle-mediated transport (GO:0060627) | NEW | 3.63 | 0.002 | APC, CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of stress-activated MAPK cascade (GO:0032872) | NEW | 4.45 | 0.021 | MET, AXIN1, TP53, CTNNB1, PIK3CA |
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124) | NEW | 5.78 | 0.046 | CASP8, TP53, CTNNB1 |
regulation of cellular component movement (GO:0051270) | - | 3.08 | 0.007 | APC, CASP8, MET, PIK3CA, MTUS1, AXIN1, TP53, CTNNB1 |
response to acid chemical (GO:0001101) | NEW | 4.05 | 0.033 | MET, IGF2R, PIK3CA, AXIN1, TP53, CTNNB1 |
response to cold (GO:0009409) | NEW | 5.9 | 0.048 | CASP8, TP53, CTNNB1 |
regulation of localization (GO:0032879) | - | 1.94 | 0.033 | APC, CASP8, MET, TP53, MTUS1, AXIN1, CTNNB1 |
negative regulation of developmental process (GO:0051093) | NEW | 3.17 | 0.03 | APC, CASP8, MET, CDKN3, AXIN1, TP53, CTNNB1, PIK3CA |
negative regulation of cellular protein metabolic process (GO:0032269) | - | 2.88 | 0.035 | APC, CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of cellular protein metabolic process (GO:0032268) | - | 1.99 | 0.0 | APC, CASP8, MET, CDKN3, AXIN1, TP53, CTNNB1, PIK3CA |
negative regulation of cardiac cell fate specification (GO:2000044) | NEW | 9.73 | 0.006 | AXIN1, CTNNB1 |
cellular response to organic cyclic compound (GO:0071407) | - | 3.93 | 0.028 | CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of lymphocyte proliferation (GO:0050670) | NEW | 4.46 | 0.032 | MET, AXIN1, TP53, CTNNB1, PIK3CA |
cell cycle process (GO:0022402) | - | 2.75 | 0.035 | APC, CASP8, MET, CDKN3, AXIN1, TP53, CTNNB1, PIK3CA |
gland development (GO:0048732) | - | 4.15 | 0.007 | MET, APC, IGF2R, CTNNB1 |
positive regulation of protein kinase activity (GO:0045860) | - | 3.61 | 0.02 | APC, CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
activation of MAPK activity (GO:0000187) | NEW | 4.79 | 0.005 | MET, TP53, AXIN1, PIK3CA, CTNNB1 |
regulation of protein stability (GO:0031647) | NEW | 4.33 | 0.004 | MET, AXIN1, CASP8, TP53, CTNNB1 |
regulation of cell activation (GO:0050865) | - | 3.53 | 0.013 | CASP8, MET, IGF2R, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of peptidyl-serine phosphorylation (GO:0033135) | - | 4.98 | 0.047 | MET, AXIN1, PIK3CA, CTNNB1 |
branching morphogenesis of an epithelial tube (GO:0048754) | - | 4.93 | 0.011 | APC, MET, AXIN1, TP53, CTNNB1 |
intrinsic apoptotic signaling pathway (GO:0097193) | NEW | 4.69 | 0.003 | TP53, CASP8, IGF2R, PIK3CA, CTNNB1 |
regulation of JUN kinase activity (GO:0043506) | NEW | 5.33 | 0.02 | MET, AXIN1, PIK3CA, CTNNB1 |
epithelial tube formation (GO:0072175) | NEW | 6.36 | 0.012 | CASP8, TP53, CTNNB1 |
liver development (GO:0001889) | - | 4.98 | 0.019 | MET, IGF2R, TP53, CTNNB1 |
positive regulation of protein serine/threonine kinase activity (GO:0071902) | NEW | 4.06 | 0.01 | CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
positive regulation of cell death (GO:0010942) | - | 3.32 | 0.014 | APC, CASP8, MET, IGF2R, PIK3CA, TP53, CTNNB1 |
canonical Wnt signaling pathway (GO:0060070) | - | 5.26 | 0.019 | APC, AXIN1, TP53, CTNNB1 |
regulation of cell death (GO:0010941) | - | 2.43 | 0.004 | APC, CASP8, MET, IGF2R, PIK3CA, TP53, CTNNB1 |
programmed cell death (GO:0012501) | - | 3.1 | 0.013 | APC, CASP8, MET, IGF2R, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of locomotion (GO:0040012) | - | 3.12 | 0.008 | APC, CASP8, MET, PIK3CA, MTUS1, AXIN1, TP53, CTNNB1 |
positive regulation of apoptotic process (GO:0043065) | - | 3.38 | 0.007 | APC, CASP8, MET, IGF2R, PIK3CA, TP53, CTNNB1 |
regulation of programmed cell death (GO:0043067) | - | 2.49 | 0.003 | APC, CASP8, MET, IGF2R, PIK3CA, TP53, CTNNB1 |
cell differentiation involved in embryonic placenta development (GO:0060706) | NEW | 6.59 | 0.015 | AXIN1, CASP8, TP53 |
positive regulation of protein maturation (GO:1903319) | NEW | 6.84 | 0.027 | AXIN1, CASP8, TP53, PIK3CA |
positive regulation of programmed cell death (GO:0043068) | - | 3.38 | 0.008 | APC, CASP8, MET, IGF2R, PIK3CA, TP53, CTNNB1 |
negative regulation of canonical Wnt signaling pathway (GO:0090090) | - | 4.63 | 0.001 | MET, APC, AXIN1, TP53, CTNNB1 |
regulation of purine nucleotide catabolic process (GO:0033121) | NEW | 8.34 | 0.032 | APC, CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of cell migration (GO:0030334) | - | 3.23 | 0.003 | APC, CASP8, MET, PIK3CA, MTUS1, AXIN1, TP53, CTNNB1 |
negative regulation of smooth muscle cell proliferation (GO:0048662) | NEW | 6.15 | 0.038 | AXIN1, TP53, CTNNB1 |
negative regulation of phosphate metabolic process (GO:0045936) | NEW | 3.45 | 0.005 | APC, CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
apoptotic process (GO:0006915) | - | 3.14 | 0.031 | APC, CASP8, MET, IGF2R, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of phosphorus metabolic process (GO:0051174) | - | 2.35 | 0.033 | APC, MET, CDKN3, AXIN1, TP53, CTNNB1, PIK3CA |
regulation of nucleoside metabolic process (GO:0009118) | NEW | 5.82 | 0.034 | APC, CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
positive regulation of protein processing (GO:0010954) | NEW | 6.9 | 0.027 | AXIN1, CASP8, TP53, PIK3CA |
canonical Wnt signaling pathway involved in negative regulation of apoptotic process (GO:0044336) | NEW | 8.63 | 0.028 | APC, CTNNB1 |
embryonic epithelial tube formation (GO:0001838) | NEW | 6.4 | 0.011 | CASP8, TP53, CTNNB1 |
positive regulation of cellular component movement (GO:0051272) | - | 3.71 | 0.026 | APC, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
axial mesoderm formation (GO:0048320) | NEW | 9.04 | 0.003 | AXIN1, TP53 |
positive regulation of locomotion (GO:0040017) | - | 3.71 | 0.038 | APC, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of cell cycle (GO:0051726) | - | 2.93 | 0.037 | APC, CASP8, MET, CDKN3, AXIN1, TP53, CTNNB1, PIK3CA |
anatomical structure development (GO:0048856) | - | 1.58 | 0.026 | APC, CASP8, MET, IGF2R, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of cellular component biogenesis (GO:0044087) | - | 3.08 | 0.036 | APC, CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
lymphocyte activation (GO:0046649) | - | 3.96 | 0.027 | APC, CASP8, TP53, CTNNB1 |
response to peptide (GO:1901652) | NEW | 3.94 | 0.004 | APC, CASP8, MET, PIK3CA, MTUS1, TP53, CTNNB1 |
regulation of organ morphogenesis (GO:2000027) | NEW | 4.22 | 0.02 | MET, APC, AXIN1, TP53, CTNNB1 |
negative regulation of protein phosphorylation (GO:0001933) | NEW | 3.79 | 0.0 | APC, CASP8, MET, PIK3CA, AXIN1, TP53, CTNNB1 |
regulation of protein phosphorylation (GO:0001932) | - | 2.57 | 0.01 | APC, MET, CDKN3, AXIN1, TP53, PIK3CA |
mitotic cell cycle checkpoint (GO:0007093) | - | 5.31 | 0.016 | MET, APC, PIK3CA, TP53 |